Literature DB >> 326328

Hypothesis. Elkind recovery and "sub-lethal damage": a misleading association?

T Alper.   

Abstract

Mesh:

Substances:

Year:  1977        PMID: 326328     DOI: 10.1259/0007-1285-50-595-459

Source DB:  PubMed          Journal:  Br J Radiol        ISSN: 0007-1285            Impact factor:   3.039


× No keyword cloud information.
  9 in total

Review 1.  The risks of handling cytotoxic drugs. I. Methods of testing exposure.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

Review 2.  Less well known parameters of in vitro radiosensitivity.

Authors:  S Vijayakumar; T C Ng; I Koumoundouros; P D Higgins; F J Thomas
Journal:  J Natl Med Assoc       Date:  1989-07       Impact factor: 1.798

Review 3.  The role of repair in radiobiology.

Authors:  T Alper; W A Cramp
Journal:  Experientia       Date:  1989-01-15

4.  Topological DNA target size model.

Authors:  D Suciu
Journal:  Radiat Environ Biophys       Date:  1990       Impact factor: 1.925

Review 5.  Are single or multiple mechanisms involved in radiation-induced mammalian cell killing?

Authors:  M M Elkind; H Utsumi; E Ben-Hur
Journal:  Br J Cancer Suppl       Date:  1987-06

6.  Kinetics of cell survival as predicted by the repair/interaction model.

Authors:  D Harder; P Virsik-Peuckert
Journal:  Br J Cancer Suppl       Date:  1984

7.  Recovery after exposure to near-ultraviolet light of cells containing 5-bromodeoxyuridine.

Authors:  M P Hagan; M M Elkind
Journal:  Biophys J       Date:  1981-06       Impact factor: 4.033

8.  Evidence for the induction of two types of potentially lethal damage after exposure of plateau phase Chinese hamster V79 cells to gamma-rays.

Authors:  G Iliakis
Journal:  Radiat Environ Biophys       Date:  1985       Impact factor: 1.925

9.  Changes in repair competency after 5-bromodeoxyuridine pulse labeling and near-ultraviolet light.

Authors:  M P Hagan; M M Elkind
Journal:  Biophys J       Date:  1979-07       Impact factor: 4.033

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.